GlassScriptPhysician profile
Adam G Newman
NPI 1225042377
$2,081.68
in general payments reported to CMS, 2019-2025
13 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,161 · 2020: $342 · 2021: $61.83 · 2022: $11.63 · 2023: $156 · 2024: $196 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,090.69 | 2019-2022 | |
| Mentor Worldwide LLC | $289.55 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Tela Bio, INC. | $154.93 | 2024 | Ovitex 2s |
| Stryker Corporation | $136.75 | 2019-2020 | |
| Abbvie INC. | $91.68 | 2023 | |
| Smith+Nephew, INC. | $75.76 | 2019 | |
| Allergan, INC. | $50.43 | 2019-2020 | |
| Motiva USA, LLC | $44.39 | 2025 | |
| Revance Therapeutics, INC. | $41.38 | 2024 | Daxxify |
| Apyx Medical Corporation | $33.00 | 2020 | |
| Kci USA, INC. | $32.17 | 2020 | |
| Organogenesis INC. | $21.59 | 2020 | |
| Solventum Corporation | $19.36 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.